- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03158467
RCT of ACP for Transplant
September 18, 2018 updated by: Abramson Cancer Center of the University of Pennsylvania
A Pilot Randomized Control Trial of Advance Care Planning and Triggered Palliative Care for Cancer Patients Undergoing Stem Cell Transplantation (RCT of ACP for Transplant)
We aim to examine the effect of an online advance directive on decisional conflict and quality of life in patients undergoing stem cell transplant.
We also aim to assess the effect of palliative care at the time of a sentinel event on quality of life.
Study Overview
Status
Withdrawn
Intervention / Treatment
Study Type
Observational
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Cancer Patients Undergoing Stem Cell Transplantation
Description
Inclusion Criteria:
The inclusion criteria for Phase I (primary objective) are as follows:
- Age ≥ 18 years
- Hematologic malignancy diagnosis including any subset of myeloma, lymphoma, leukemia, or myelodysplastic syndrome
- Currently scheduled for autologous or allogeneic transplant at the Hospital of the University of Pennsylvania
The inclusion criteria for Phase II (secondary objective) are as follows:
- Age ≥ 18 years
- Hematologic malignancy diagnosis including any subset of lymphoma, leukemia, or myelodysplastic syndrome
- Received an autologous or allogeneic stem cell transplant at the Hospital of the University of Pennsylvania and experienced a sentinel event of either 1) disease relapse,2) severe (Grade III or IV) graft-versus-host disease, or 3) unplanned hospital admission with length of stay greater than 72 hours.
Exclusion Criteria:
The exclusion criteria for Phase I include:
- Inability to read and write English
- Not serving as the primary decision maker for their health-related decisions
- Having a non-hematologic malignancy reason for undergoing transplantation (e.g. aplastic anemia)
The exclusion criteria for Phase II include:
- Not completing participation in Phase I of the study
- Myeloma diagnosis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Phase 1
|
Instruments will be administered via the online RedCAP platform.
The survey instruments will include a Decision Conflict Scale (DCS), the McGill Quality of Life (MQoL), the Human Connection (THC), and a general demographics questionnaire.
Patients will have the opportunity to complete the instruments via a research iPad while in clinic or via a survey link emailed to their private email account.
|
Phase 2
|
Instruments will be administered via the online RedCAP platform.
The survey instruments will include a Decision Conflict Scale (DCS), the McGill Quality of Life (MQoL), the Human Connection (THC), and a general demographics questionnaire.
Patients will have the opportunity to complete the instruments via a research iPad while in clinic or via a survey link emailed to their private email account.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of surveys completed
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Pallavi Kumar, MD, Abramson Cancer Center of the University of Pennsylvania
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 15, 2017
Primary Completion (Anticipated)
May 15, 2019
Study Completion (Anticipated)
November 15, 2019
Study Registration Dates
First Submitted
May 16, 2017
First Submitted That Met QC Criteria
May 16, 2017
First Posted (Actual)
May 18, 2017
Study Record Updates
Last Update Posted (Actual)
September 20, 2018
Last Update Submitted That Met QC Criteria
September 18, 2018
Last Verified
May 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- UPCC 23417
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer Patients Undergoing Stem Cell Transplantation (RCT of ACP for Transplant)
-
University of Erlangen-Nürnberg Medical SchoolGerman Research Foundation; Charite University, Berlin, Germany; Ludwig-Maximilians... and other collaboratorsCompletedPatients Undergoing Allogeneic Stem Cell TransplantationGermany
-
National Institute of Mental Health (NIMH)CompletedCancer | Bone Marrow Transplantation | Allogeneic Peripheral Blood Stem Cell TransplantUnited States
-
M.D. Anderson Cancer CenterTerminatedBlood Stem Cell Transplant Failure | Disorder Related to Bone Marrow Transplantation | Transmission, Blood, Recipient/Donor | Disturbance of Emotions Specific to Childhood and Adolescence | SiblingUnited States
-
Hebei Yanda Ludaopei HospitalNot yet recruitingNutrition Aspect of Cancer | Stem Cell Transplant Complications
-
Yonsei UniversityUnknownMultiple Myeloma Patients Who Candidate for Autologous Peripheral Blood Stem Cell TransplantationKorea, Republic of
-
Nottingham University Hospitals NHS TrustUniversity of Nottingham; University of Sheffield; Sheffield Teaching Hospitals...CompletedNutrition Aspect of Cancer | Stem Cell Transplant Complications | Prehabilitation | Haematological Malignancy | Nutritional and Metabolic Disease | Bone Marrow Transplant Complications | Exercise InterventionsUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterTerminatedThe Families or Next of Kin of Patients Treated at MSKCC for Non-cutaneous Squamous Cell Carcinomas of the | Upper Aerodigestive TractUnited States
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI); University of California, San Diego; Hackensack...CompletedQuality of Life | Breast Cancer | Fatigue | Sleep | Mild Cognitive Impairment | Hematopoietic Stem Cell Transplantation | LightUnited States
-
Assistance Publique - Hôpitaux de ParisRecruitingPediatric Patients | Any Type of Severe Combined Immunodeficiency (SCID) | Partial HLA Incompatible Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)France
-
Fred Hutchinson Cancer CenterActive, not recruitingMyasthenia Gravis | Neuromyelitis Optica | Autoimmune Disease | Chronic Inflammatory Demyelinating Polyneuropathy | Lambert Eaton Myasthenic Syndrome | Cerebellar Degeneration | Stiff Person Syndrome | Opsoclonus Myoclonus Syndrome | Neurologic Autoimmune Disease | Autologous Transplant Autoimmune | Multiple... and other conditionsUnited States
Clinical Trials on Surveys
-
Memorial Sloan Kettering Cancer CenterCompletedRectal Cancer | Colon CancerUnited States
-
University of MichiganNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruiting
-
RANDClaremont Graduate UniversityCompleted
-
Elysium HealthUniversity of OxfordNot yet recruitingBiological Aging
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedMuscle-Invasive Bladder Carcinoma | Bladder Cancer Stage II | Bladder Cancer Stage III | Bladder Cancer Stage IVUnited States
-
University Hospital, AngersCompletedOpioid-Related Disorders | Critically Ill | Pain, ChronicFrance
-
Mayo ClinicCompletedCesarean SectionUnited States
-
Hospital for Special Surgery, New YorkCompletedPain, Postoperative | TSA | BruiseUnited States
-
Northwestern UniversityCompleted